Academic Journal
Q1Gynecologic Oncology
About Gynecologic Oncology
Gynecologic Oncology is a scholarly journal published by Academic Press Inc.. SCImago 2025 places it in Q1 with an SJR of 1.81 and an H-index of 198.
Its listed coverage is 1972-2026 and its research categories include Obstetrics and Gynecology (Q1); Oncology (Q1). The 2025 dataset reports 311 documents and 4228 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cervical Cancer and HPV Research, Uterine Myomas and Treatments, Intraperitoneal and Appendiceal Malignancies, PARP inhibition in cancer therapy.
Recent Research Articles
Latest publications matched automatically by ISSN.
Molecular groups predict response to fertility-sparing treatment of endometrial carcinoma: a systematic review and metanalysis
Antonio Raffone, Daniele Neola, Angelica Tranchini, Maria Mele et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.08.021Molecular characterization of NSMP endometrial cancer and its relevance for treatment
Tarik Silk, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos
2026-10 · DOI: 10.1016/j.ygyno.2026.08.017Prognostic implications of HPV and TP53 status in early-stage vulvar squamous cell carcinoma
Simrit K. Warring, Evdokiya E. Knyazhanskaya, Allison E. Garda, William A. Cliby et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.08.020High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention
Elizabeth G. Thayer, Zoe A. Roecker, Kelsey A. Roof, Hannah B. Gold et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.08.019Minimally invasive surgery without a uterine manipulator versus open radical hysterectomy for early-stage cervical cancer: A retrospective propensity-score-matched single-center cohort study
Lusi Deng, Ying Zheng, Fan Yang, Qiao Wang et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.08.022Mutated p53 results in altered type I interferon pathway expression and signaling in endometrial cancer
Annalyn M. Welp, Alex R. Mabry, Caleb L. Lines, Premal H. Thaker et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.08.016Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201
Rachel N. Grisham, Els Van Nieuwenhuysen, Alessandro D. Santin, Véronique D'Hondt et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.09.003Planning and feasibility of phase III surgical trials in gynecologic oncology
Alexandra S. Bercow, Nuria Agusti, Pedro Ramírez, Anne Knisely et al.
2026-10 · DOI: 10.1016/j.ygyno.2026.08.018Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia
Raphael Alevato, Antônio Braga, Gabriela Paiva, Edward Aurajo Júnior et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.08.008Pregnancies in gynecologic oncologists: An assessment of pregnancy policies and complications within a surgical subspecialty
Kelsey C. Goon, Julie Chor, Kathryn A. Mills
2026-09 · DOI: 10.1016/j.ygyno.2026.07.020The feasibility of a medically supervised preoperative weight loss program in patients with obesity and atypical hyperplasia, or low-grade endometrial carcinoma
Christa Aubrey, Bruno Svajger, Jesse Batara, Sarah Chapelsky et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.07.024TOC
2026-09 · DOI: 10.1016/s0090-8258(26)02124-4The science and conduct of surgical trials in gynecologic oncology: A practical framework
Nuria Agustí, Alexandra Bercow, Anne Knisely, Andreas Obermair et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.08.013Understanding and addressing enrollment gaps and opportunities in gynecologic oncology clinical trials: A scoping review
Teresa K.L. Boitano, Ankit Bansal, Kaitlyn G. Dinkins, Victoria Fennell et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.07.015Feasibility, adherence, and patient experiences in a pilot randomized trial of home-based cognitive training intervention for gynecologic cancer-related cognitive impairment
Connor C. Wang, Isabelle Kildee, Emma Reasner, Isabelle Bednorski et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.08.001Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypes
Orazio De Tommasi, Luca Palmieri, Stefania Bellone, Natalia Buza et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.08.002Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980–2023) with focus on younger women (0–49 years old)
Charlotta Riese, Enoch Yi-Tung Chen, Hanna Nilsson, Sahar Salehi et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.08.014Phase 1–3 cross-cultural development and pre-testing of the European Organisation of Research and Treatment of Cancer Vulva cancer questionnaire module (EORTC QLQ- VU)
Ligita Paskeviciute Froeding, Eva Greimel, Andy Nordin, Ingvild Vistad et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.07.014Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials
Emily M. Ko, Christine Pae, Lakeisha Mulugeta-Gordon, Destiny Uwawaike et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.08.004Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial
Shannon N. Westin, Jimmy Belotte, Brunella Felicetti, Vishvajit Aghera et al.
2026-09 · DOI: 10.1016/j.ygyno.2026.07.023Reviews
Community Reviews
Version History
September 8, 2026 at 12:04 am
September 8, 2026